SUD Reprocessing, Tissue Regulation Addressed By Australia’s TGA
This article was originally published in The Gray Sheet
Executive Summary
Device manufacturers will have a two-year phase-in period to comply with new 1single-use device reprocessing regulatory requirements proposed by Australia's Therapeutic Goods Administration